As the American healthcare landscape faces unprecedented turbulence, a growing number of clinicians are stepping away from the bedside and into the political arena. Among the most prominent of these voices is Dr. Richard Pan, a pediatrician and former California state senator who is currently mounting a campaign for a seat in the U.S. House of Representatives.
In a wide-ranging conversation with MedPage Today, Dr. Pan detailed his transition from a biophysics-focused researcher to a frontline advocate for public health policy. His journey, marked by both scientific rigor and legislative grit, offers a unique perspective on the intersection of medicine and governance in the modern era.
The Evolution of a Physician-Advocate
Dr. Pan’s career trajectory is a testament to the "micro-to-macro" evolution of modern medicine. Early in his academic life at Johns Hopkins University, his focus was firmly rooted in the laboratory. As a biophysics major, he was driven by the prospect of discovering the next great medical breakthrough, pouring his energy into the study of gene expression and protein structures.
However, as his training progressed through the University of Pittsburgh School of Medicine, his perspective began to shift. He became increasingly preoccupied with the social determinants of health—the external factors that dictate the longevity and wellness of entire populations.
His transition toward advocacy was catalyzed by tragedy. During his final year of medical school, he served with the U.S. Public Health Service Commissioned Corps in Philadelphia during a devastating measles outbreak in 1991. The experience was harrowing: he witnessed over 1,000 infections and the deaths of nine children. It was a formative moment that transformed his understanding of infectious disease from a clinical problem to a systemic one.
Following a pediatric residency at Massachusetts General Hospital and a fellowship in child advocacy and primary care research at Boston Children’s Hospital, Dr. Pan settled in Sacramento, California, joining the faculty at UC Davis. There, he expanded his impact by launching a residency program that emphasized community health, pushing the next generation of pediatricians to step out of the clinic and into the neighborhoods they served.
Chronology: A Legislative Record of Resilience
Dr. Pan’s foray into politics was not part of a grand design but rather a response to the economic and social fallout of the Great Recession. Seeing the gaps in the social safety net, he sought a seat in the California state legislature. Despite being an outsider in a crowded political landscape, he won—launching a 12-year tenure that saw him champion some of the most controversial and consequential public health laws in the state’s history.
The Vaccine Battles
Dr. Pan’s legislative career became inextricably linked to the fight for immunization standards. Recognizing a decline in vaccination rates through his leadership in the California chapter of the American Academy of Pediatrics, he observed the rise of vaccine hesitancy fueled by the debunked Andrew Wakefield study and the rapid spread of misinformation on social media.
- 2012: Dr. Pan authored his first vaccine bill, which required parents seeking a personal belief exemption to provide proof that they had consulted with a healthcare provider about the risks of skipping immunizations.
- 2015: Following a major measles outbreak linked to Disneyland, Dr. Pan teamed up with state Senator Ben Allen to author landmark legislation that abolished non-medical exemptions for school-aged children.
- The Backlash: The effort drew intense vitriol. Dr. Pan recalls receiving death threats and facing intimidation from high-profile anti-vaccine activists, including Robert F. Kennedy Jr. and Mary Holland of the Children’s Health Defense, who testified against the bill.
- 2019: Facing a resurgence of measles, Dr. Pan authored further legislation to crack down on a small subset of physicians who were illicitly selling medical exemptions, ensuring the integrity of the state’s immunization program.
Supporting Data: The Measles Resurgence
The stakes of Dr. Pan’s legislative work are highlighted by current national health data. According to federal reporting, the U.S. is currently grappling with thousands of measles cases—a stark contrast to the decade-long period of relative dormancy that preceded recent policy shifts.
Dr. Pan points to the death of four children from measles this year as a primary indicator of policy failure. When compared to the stable environment of the early 2010s, these figures represent a significant regression in public health outcomes. Furthermore, the rising frequency of foodborne illness recalls—specifically involving Cyclospora and Salmonella—serves as an indicator of broader systemic instability within the agencies tasked with public protection.
Official Responses and Political Implications
The central theme of Dr. Pan’s congressional bid is his vehement opposition to the current administration’s approach to public health, particularly the appointment of Robert F. Kennedy Jr. as HHS Secretary.
The Critique of HHS Leadership
Dr. Pan does not mince words regarding the current leadership at the Department of Health and Human Services. He characterizes the current HHS direction as "dangerous and incompetent," arguing that the agency has shifted from a guardian of public health to a source of confusion.
"We have someone who is doing everything he can to sow confusion, to undermine trust, and is actively putting the American people in danger," Dr. Pan stated. He draws a direct line between the current administration’s rhetoric and the degradation of trust in institutions like the CDC and the FDA.
Economic Policy as Public Health
Beyond infectious disease, Dr. Pan identifies economic stability as a primary public health concern. He criticizes the reduction of Medicaid funding and the erosion of Affordable Care Act (ACA) tax credits, noting that these cuts disproportionately affect middle-class families.
"Poverty is a social determinant of health," he argues. "When households are falling behind, they cannot make ends meet, and that is not good for their health." Dr. Pan suggests that the increased bureaucratic hurdles for Medicaid—such as strict work requirements—are designed to limit access for those who qualify, ultimately resulting in higher costs for the healthcare system as patients delay care until their conditions become acute.
Addressing the Medicare Crisis
One of the most pressing concerns for the medical community is the sustainability of the Medicare physician payment system. Dr. Pan identifies the current "budget neutrality" requirement for physicians as fundamentally dysfunctional.
"Physicians are the only providers who have to meet these strict budget neutrality requirements," he noted. "If we continue on this path, we are going to see a mass exodus of physicians from Medicare. They want to take care of our seniors, but they are being forced into a corner where it becomes financially untenable to do so."
For Dr. Pan, the solution lies in a structural overhaul of how the federal government values clinical labor. He warns that without legislative intervention, the country faces a looming crisis in access to care for the elderly, a demographic that is rapidly expanding.
Conclusion: The Path Forward
Dr. Richard Pan’s campaign for Congress is framed as a mission to restore evidence-based policymaking in Washington. Whether discussing the mechanics of vaccine immunity or the intricacies of Medicaid reimbursement, he consistently returns to the necessity of expertise in governance.
In a political climate where scientific consensus is often treated as a matter of opinion, Dr. Pan’s candidacy represents a push to return the medical profession to its role as a primary advisor to the state. As he looks toward the upcoming election, his platform remains clear: a commitment to protecting the most vulnerable through the lens of proven science, the strengthening of the social safety net, and the restoration of trust in the nation’s public health infrastructure.
For many in the medical field, his candidacy serves as a litmus test for whether the healthcare community can successfully translate clinical experience into meaningful, nationwide legislative reform.
